Posts by Rochelle P. Walensky, MD, MPH
-
COVID-19 Vaccines: Proper Implementation as Important as Efficacy
Rochelle P. Walensky, MD, MPH, former chief of the Division of Infectious Diseases, and colleagues demonstrate in a mathematical model that the benefits of any COVID-19 vaccine will depend as much on how fast and broadly it's implemented and the severity of the epidemic as on the vaccine's efficacy in clinical trials.
-
Suboptimal Antibiotic Prescribing May Be Common for Patients with Documented Penicillin Allergy
In a nationwide study, 16% of inpatients that had a penicillin allergy noted on their medical record—not necessarily confirmed by formal testing— were at high risk of receiving a β-lactam alternative antibiotic.
-
MGH Research Scholars Respond to COVID-19
This video highlights how the MGH Research Scholars rapidly mobilized to address key medical and scientific challenges posed by COVID-19.
-
Medical Grand Rounds: COVID-19: Public Health and Scientific Challenges Featuring Dr. Anthony Fauci
On September 10, 2020, the Department of Medicine held a virtual Grand Rounds on COVID-19. Anthony S. Fauci, MD, National Institute of Allergy and Infectious Diseases (NIAID) director, spoke to the Boston medical community about COVID-19 public health and scientific challenges.
Biography
Dr. Rochelle Walensky, MD, MPH, is Professor of Medicine at Harvard Medical School and a practicing Infectious Disease physician at Massachusetts General Hospital and Brigham and Women's Hospital.
Dr. Walensky's research interests focus on model-based analyses of the cost-effectiveness of HIV testing, care, and prevention strategies to inform HIV/AIDS policy internationally and domestically.
Using both traditional novel methods of microsimulation modeling and decision analysis, Dr. Walensky has been active in and nationally recognized for motivating health policy and informing clinical trial design and evaluation in a variety of settings.
In addition, Dr. Walensky has been influential in advancing international health policy towards the promotion of HIV treatment as prevention (TasP) and the adoption of other effective and efficient strategies of HIV care.
Dr. Walensky serves as Chair of the Office of AIDS Research Advisory Council (NIH) and as a member of the US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.
